ERICA BURNETT: Open Payments
NPI 1659649515 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,409 in 114 payments from 27 companies in 2025. Trend: 2023 $1,693 · 2024 $1,974 · 2025 $2,409
Food & beverage: $2,409
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $462 |
| Novo Nordisk Inc | 19 | $404 |
| Insulet Corporation | 9 | $165 |
| Lilly USA, LLC | 8 | $142 |
| Boston Scientific Corporation | 9 | $139 |
| Amneal Pharmaceuticals LLC | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| CeQur Corporation | 1 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| Tandem Diabetes Care, Inc. | 5 | $78 |
Products named: Ozempic, TEPEZZA, Omnipod, WATCHMAN FLX, JARDIANCE, MOUNJARO, UNITHROID, LEQVIO.
Industry payments across GA — which companies pay providers there.
